Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD36 and atherosclerosis.

R L Silverstein1, M Febbraio

  • 1Weill Medical College of Cornell University, Department of Medicine, New York, New York 10021, USA.

Current Opinion in Lipidology
|October 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of a mouse model to study the relationship between apical periodontitis and atherosclerosis.

International endodontic journal·2020
Same author

Association between apical periodontitis and cardiovascular diseases: a systematic review of the literature.

International endodontic journal·2016
Same author

Thrombospondin-1 restrains neutrophil granule serine protease function and regulates the innate immune response during Klebsiella pneumoniae infection.

Mucosal immunology·2014
Same author

Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury.

Mucosal immunology·2013
Same author

P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.

International journal of laboratory hematology·2012
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
Same journal

HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?

Current opinion in lipidology·2026
See all related articles

Cluster of Differentiation 36 (CD36) plays a key role in various cellular processes and diseases. Recent genetic advancements highlight its in-vivo relevance, paving the way for targeted therapies.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Cluster of Differentiation 36 (CD36) is a scavenger receptor involved in lipid metabolism and cellular adhesion.
  • Its roles span normal physiological processes and various pathological conditions, including atherosclerosis and diabetes.
  • Despite being identified over 25 years ago, its in-vivo significance is only recently being elucidated through advanced genetic technologies.

Purpose of the Study:

  • To review the diverse functions of CD36 in both normal and pathological contexts.
  • To emphasize the growing in-vivo evidence supporting the physiological and pathological relevance of CD36.
  • To highlight the potential for developing targeted therapeutics based on CD36 signaling mechanisms.

Main Methods:

Related Experiment Videos

  • Review of existing literature and recent genetic studies.
  • Analysis of in-vivo evidence for CD36's roles.
  • Exploration of CD36 signaling pathways.

    • Main Results:

    • CD36 mediates critical functions such as apoptotic cell uptake, lipid metabolism, and inflammation modulation.
    • In-vivo studies increasingly confirm CD36's involvement in diseases like atherosclerosis, diabetes, and cardiomyopathy.
    • Emerging evidence points to CD36's role in angiogenesis and transforming growth factor-beta activation.

    Conclusions:

    • CD36 is a multifunctional protein with significant implications in human health and disease.
    • Advancements in genetic technology are crucial for understanding CD36's in-vivo functions.
    • Further research into CD36 signaling mechanisms will enable the development of novel therapeutic strategies.